Alzheimer’s disease could affect more than 14 million Americans by 2050 if a cure isn’t found, the Alzheimer’s Association reports. The Center for Alzheimer’s Disease and Related Disorders, part of SIU Medicine’s Neuroscience Institute, is hoping new research studies might change that. Three clinical trials, including the Aware Study by AbbVie, Tauriel Study by Genentech, and GRADUATE I Study by Roche, are now recruiting participants with memory impairment or probable mild-to-moderate Alzheimer’s disease. The goal of these studies is test how well the medical treatments work at slowing the

SIU Medicine audiologist Jennifer L. Berry, AuD, CCC-A, took the title "Best Audiologist" in the Illinois Times' 2018 Best of Springfield awards. Hundreds of readers took to the internet to cast their votes for their favorite restaurants, health care providers, dry cleaners and more in the annual contest. Berry specializes in treating hearing loss and tinnitus and provides cochlear implant services, hearing screenings and hearing aid services. She joined SIU Medicine's Department of Surgery after spending several years researching hearing loss and tinnitus. Berry sees patients at the Ear Nose

SIU Medicine audiologist Jennifer L. Berry, AuD, CCC-A, took the title "Best Audiologist" in the Illinois Times' 2018 Best of Springfield awards. Hundreds of readers took to the internet to cast their votes for their favorite restaurants, health care providers, dry cleaners and more in the annual contest. Berry specializes in treating hearing loss and tinnitus and provides cochlear implant services, hearing screenings and hearing aid services. She joined SIU Medicine's Department of Surgery after spending several years researching hearing loss and tinnitus. Berry sees patients at the Ear Nose

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper

SPRINGFIELD, ILLINOIS: If you could take a drug that would help cure your cancer, but it would make you go deaf, would you still take the drug? Cisplatin is a widely used anticancer drug that unfortunately carries some major side effects, including hearing loss and damage to the nerves and kidneys. Its high toxicity often requires dose reductions or the use of less effective alternate drugs. Cisplatin-induced hearing loss can range from 50-75 percent in adults. When the drug is used to treat neuroblastomas in pediatric cancer patients, extreme care must be taken because hearing loss can hamper